Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...
A Pennsylvania-based pharmaceutical firm and the FDA issued a recall of an injectable blood pressure medicine after a customer noticed "a visible black particulate matter" in a vial. Dr. Bernard Ashby ...
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.
The FDA says administering a drug containing particulate matter may cause local irritation or swelling. If the particulates enter blood vessels, it can travel to various organs and potentially ...
Provepharm is recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10 mg/ ...
It was manufactured by a well-known pharmaceutical company and may be used to treat a specific group of patients managing hypertension.
It's not the only blood pressure medication recall to happen in recent months, but the FDA's concern appears to follow a common theme.
The FDA labeled a recall of integrated arterial catheters made by Medline Class I, the most serious kind of recall.
“If the particulate matter enters the blood vessels, it can travel to various organs and potentially block blood vessels in the heart, lungs or brain, leading to serious complications such as stroke ...
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...